The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic uncertainties that have impacted investor sentiment. In such a climate, identifying small-cap stocks with potential value can be crucial for investors looking to navigate these turbulent times effectively. Top 10 Undervalued Small Caps With Insider Buying In The United Kingdom Name PE PS Discount to Fair Value Value Rating Senior 17.8x 0.6x 38.10% ★★★★★★ Bytes Technology Group 22.0x 5.6x 12.14% ★★★★★☆ NWF Group 8.1x 0.1x 38.88% ★★★★★☆ Genus 174.6x 2.1x 6.75% ★★★★★☆ Headlam Group NA 0.2x 26.69% ★★★★★☆ Essentra 728.5x 1.4x 26.23% ★★★★☆☆ Marlowe NA 0.7x 41.54% ★★★★☆☆ Optima Health NA 1.3x 37.24% ★★★★☆☆ Robert Walters 41.5x 0.2x 42.00% ★★★☆☆☆ Petra Diamonds NA 0.3x -44.22% ★★★☆☆☆ Click here to see the full list of 30 stocks from our Undervalued UK Small Caps With Insider Buying screener. Below we spotlight a couple of our favorites from our exclusive screener. Domino's Pizza Group Simply Wall St Value Rating: ★★★★★☆ Overview: Domino's Pizza Group operates as a leading pizza delivery and carryout chain, generating income through sales to franchisees, corporate stores, advertising and ecommerce, property rentals, and various franchise-related fees; it has a market capitalization of £1.53 billion. Operations: The primary revenue streams include sales to franchisees, corporate store income, and royalties. The gross profit margin has shown a trend of increasing over time, reaching 47.48% as of June 2024. Operating expenses are significant and include costs such as sales & marketing and general & administrative expenses. PE: 15.5x Domino's Pizza Group, a smaller company in the UK market, is navigating challenges with lower profit margins, now at 11.4% compared to last year's 18.2%. Despite high debt levels and reliance on external borrowing, their strategic initiatives aim for growth in orders and sales through fiscal year 2024. Insider confidence is evident with share repurchases totaling £90.1 million by May 2024. The interim dividend of £0.035 per share underscores their commitment to shareholder returns amidst these dynamics. Take a closer look at Domino's Pizza Group's potential here in our valuation report. Understand Domino's Pizza Group's track record by examining our Past report. LSE:DOM Share price vs Value as at Oct 2024 Genus Simply Wall St Value Rating: ★★★★★☆ Overview: Genus is a company specializing in animal genetics, focusing on bovine and porcine breeding, with a market cap of approximately £1.92 billion. Operations: Genus generates revenue primarily from its Genus ABS and Genus PIC segments, contributing £314.90 million and £352.50 million respectively. The company experienced fluctuations in its gross profit margin, reaching a high of 53.78% in December 2014 before declining to 36.25% by December 2023. Operating expenses are significant, with research and development costs consistently around the £72-93 million range over recent periods. PE: 174.6x Genus, a UK-based company, recently proposed a final dividend of 21.7 pence per share, maintaining its commitment to shareholders. Despite reporting a decrease in sales to £668.8 million and net income dropping to £7.9 million for the year ending June 2024, insider confidence is evident with recent share purchases by company insiders throughout the year. The firm navigates primarily through external borrowing but forecasts suggest potential earnings growth of 37% annually, hinting at future opportunities for investors seeking undervalued stocks. Unlock comprehensive insights into our analysis of Genus stock in this valuation report. Review our historical performance report to gain insights into Genus''s past performance. LSE:GNS Share price vs Value as at Oct 2024 Oxford Instruments Simply Wall St Value Rating: ★★★★☆☆ Overview: Oxford Instruments is a company that specializes in providing high-technology tools and systems for research, discovery, service, healthcare, materials analysis, and characterization with a market cap of £1.34 billion. Operations: Research & Discovery, Service & Healthcare, and Materials & Characterisation contribute to Oxford Instruments' revenue streams. The company reported a gross profit margin of 52.24% as of September 30, 2023. Operating expenses are primarily driven by sales and marketing, R&D, and general administrative costs. PE: 24.3x Oxford Instruments, a smaller player in the UK market, has caught attention with its promising growth prospects. Their earnings are projected to rise by 10.45% annually, indicating potential for future expansion. Despite relying solely on external borrowing for funding, which poses some risk, insider confidence is evident as insiders have been purchasing shares over recent months. Recent participation in high-profile conferences like the Geotechnologist Symposium and NanoFabUK highlights their active engagement within industry circles and commitment to innovation. Navigate through the intricacies of Oxford Instruments with our comprehensive valuation report here. Gain insights into Oxford Instruments' past trends and performance with our Past report. LSE:OXIG Share price vs Value as at Oct 2024 Where To Now? Reveal the 30 hidden gems among our Undervalued UK Small Caps With Insider Buying screener with a single click here. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Looking For Alternative Opportunities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:DOM LSE:GNS and LSE:OXIG. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
United Kingdom's Top 3 Undervalued Small Caps With Insider Buying
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...